Comparing two acid reducers for severe ulcer bleeding
Treatments studied
Part of Digestive system clinical trials.
This trial compares two types of acid-reducing medicines to see which is better at preventing re-bleeding in people who have had severe ulcer bleeding. If you qualify, you would receive either a new acid blocker or a double dose of a standard acid reducer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (over 18 years old).
- You are currently in the hospital for bleeding from a stomach or intestinal ulcer.
- You have a high risk score (Rockall score of 6 or more) for this bleeding.
- You have had an endoscopic procedure to stop the bleeding.
- You are not allergic to acid-reducing medications, and you do not have severe liver or kidney problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two medicines that lower stomach acid to help stop bleeding from the stomach or intestines. It aims to find which one works better for people with this type of bleeding.
This study compares two medications, vonoprazan and esomeprazole, to see which works better for healing damage to the esophagus caused by acid reflux (erosive esophagitis). If you have this condition, this trial could help find you the most effective treatment.
This trial compares an IV “acid-suppressing” medicine (PPI infusion) with acid pills (oral PPIs) after doctors treat a bleeding peptic ulcer endoscopically. It may help prevent re-bleeding by keeping stomach acid low while the ulcer heals.
This study tests two different acid-reducing medicines (rabeprazole and vonoprazan) to see which one better prevents painful ulcers that can develop after a procedure to tie off bleeding veins in the esophagus. If you have cirrhosis and bleeding veins, this trial may help protect your healing.
This trial tests vonaprazan (two doses) against esomeprazole to see which better heals moderate-to-severe reflux esophagitis (a damaged esophagus from acid reflux) in 8 weeks. You may qualify if you have had heartburn or regurgitation for at least a month and your doctor found grade B, C, or D damage on an endoscopy.
This trial compares two acid-reducing medicines—Tegoprazan and Lansoprazole—to see which works better for stopping bleeding from a peptic ulcer. If you have a confirmed upper GI bleed from an ulcer, this study may help find the best treatment for you.
Hear when a new Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.